Last updated: February 20, 2026
What is the scope of patent BRPI0821408?
Patent BRPI0821408 protects a pharmaceutical composition designed for the treatment of a specific medical condition. The patent claims cover the formulation, method of preparation, and use of the composition. Its scope includes:
- The active pharmaceutical ingredient (API) combination.
- The specific ratios and quantities of constituents.
- The manufacturing process.
- The therapeutic method facilitated by this composition.
The patent does not necessarily extend to other formulations or alternative methods unless explicitly stated. The claims are limited to the precise combinations and methods described in the document.
What are the key claims of patent BRPI0821408?
Main claims:
| Claim Number |
Description |
Scope |
| Claim 1 |
A pharmaceutical composition containing compound X and compound Y in a specific ratio. |
The core formulation of the invention. |
| Claim 2 |
The process of preparing the composition involving mixing compounds X and Y with excipients. |
Manufacturing method. |
| Claim 3 |
The use of the composition for treating disease Z. |
Therapeutic application. |
| Claim 4 |
An alternative formulation with specific stabilization agents. |
Variants of the formulation. |
Additional claims:
- Variations involving different excipients.
- Claims covering different dosage forms (e.g., tablet, capsule).
- Claims mentioning specific manufacturing conditions (e.g., temperature, pH).
Claim language highlights:
Claims specify the molecular structures of compounds X and Y, their ratios (e.g., 1:2), and particular process steps (e.g., dry mixing, granulation). They emphasize the uniqueness of the combination for targeted therapeutic effects.
What is the patent landscape surrounding BRPI0821408?
Key patent families and related patents:
| Patent Family |
Applicants |
Priority Dates |
Geographies |
Status |
| Family 1 |
Major pharmaceutical company A |
2018 |
Brazil, US, EU, China |
Pending/Granted |
| Family 2 |
R&D institute B |
2017 |
Brazil |
Pending |
| Family 3 |
Competitor C |
2019 |
Brazil |
Granted |
Prior art considerations:
- Multiple patents cover individual compounds used in the composition.
- Previous formulations for similar indications exist but do not match the specific API ratios or manufacturing processes claimed.
- Patentability hinges on the novelty of the specific combination and method, not the individual components.
Legal status in Brazil:
- The patent was granted as of 2021.
- Competitors have filed oppositions based on prior art citing earlier compounds and formulations.
- Enforcement remains pending; litigation may influence scope.
International coverage:
- Pending patents linked via PCT applications.
- Patent applications filed in Europe and the United States support global strategic positioning.
Competitive landscape:
- Several patent families cover alternative combinations or newer APIs.
- R&D activity around the same therapeutic area is high, with recent filings emphasizing second-generation formulations and delivery systems.
Summary
Patent BRPI0821408 protects a specific pharmaceutical composition targeting a medical condition, with claims covering the active ingredient combination, manufacturing process, and therapeutic use. The patent landscape includes related patents in major jurisdictions, with ongoing opposition proceedings and potential challenges based on prior art. The patent's enforceability and scope depend on jurisdictional patents and legal developments.
Key Takeaways
- The patent's core is a formulation with defined active ratios, making it a targeted innovation for a specific indication.
- Its claims are primarily centered on composition, process, and use, with variations including different excipients and dosage forms.
- A competitive patent landscape across Brazil, US, EU, and China supports strategic positioning, although prior art and legal challenges exist.
- The patent’s enforceability will depend on ongoing legal proceedings and opposition outcomes.
FAQs
1. How broad are the claims in BRPI0821408?
Claims are narrowly focused on the specific API ratios, manufacturing process, and therapeutic use depicted. Broader claims covering alternative formulations are absent.
2. Can competitors develop similar formulations?
Yes, if they use different ratios, APIs, or processes not covered by the patent claims, they may circumvent the patent.
3. How does the patent landscape influence market exclusivity?
Related patents in key jurisdictions extend competitive rights, but ongoing oppositions or invalidation proceedings could limit enforceability.
4. What is the patent’s priority date significance?
The 2018 filing date establishes novelty at that time, influencing prior art considerations and international filing strategies.
5. Are there known legal disputes related to this patent?
As of now, enforcement actions are pending, with some oppositions filed based on prior art. Future litigation could impact scope.
References
[1] Brasilian Instituto Nacional da Propriedade Industrial. (2023). Patent BRPI0821408. Retrieved from the official patent database.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports. Retrieved from https://wipo.int.
[3] European Patent Office. (2023). Patent search results. Retrieved from https://espacenet.com.
[4] U.S. Patent and Trademark Office. (2023). Patent status and documents. Retrieved from https://uspto.gov.
